5 citations
,
January 2019 in “Revista Latino-americana De Enfermagem” In this study, the direct cost of producing autologous platelet rich plasma gel in a Rio de Janeiro university hospital was found to be US $4.88 per session, highlighting its potential as a low-cost and accessible treatment option within the Unified Health System.
June 2024 in “Дерматовенерология Косметология” In this study, treatment with autologous follicular stem cells improved hair conditions in 57% of patients with androgenic and telogen effluvium alopecia, as confirmed by phototrichograms, indicating its potential effectiveness for non-scarring alopecia.
39 citations
,
January 2021 in “BioMed Research International” This review explores the variability in platelet-rich plasma therapy outcomes across different medical applications, attributing disparities to inconsistent blood processing methods, and it reports no new clinical results.
May 2019 in “Cytotherapy” This study explored how Australian patients and their carers perceived autologous stem cell interventions, highlighting factors like illness experience and unrealistic expectations that influenced their decision-making in an unregulated market.
20 citations
,
May 2015 in “Regenerative Medicine” This commentary explores the marketing of unproven and unlicensed adipose-derived stem cell treatments in US clinics, highlighting concerns about patient safety and regulatory challenges.